Suppr超能文献

相似文献

1
The interleukin-1 family: back to the future.
Immunity. 2013 Dec 12;39(6):1003-18. doi: 10.1016/j.immuni.2013.11.010.
2
Negative regulatory receptors of the IL-1 family.
Semin Immunol. 2013 Dec 15;25(6):408-15. doi: 10.1016/j.smim.2013.10.019. Epub 2013 Nov 14.
3
Negative Regulation of the IL-1 System by IL-1R2 and IL-1R8: Relevance in Pathophysiology and Disease.
Front Immunol. 2022 Feb 8;13:804641. doi: 10.3389/fimmu.2022.804641. eCollection 2022.
4
Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity.
J Biol Chem. 2011 Dec 9;286(49):42594-42602. doi: 10.1074/jbc.M111.267922. Epub 2011 Sep 29.
5
The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases.
Cytokine. 2015 Nov;76(1):25-37. doi: 10.1016/j.cyto.2015.06.017. Epub 2015 Jul 13.
6
Decoys and Regulatory "Receptors" of the IL-1/Toll-Like Receptor Superfamily.
Front Immunol. 2013 Jul 9;4:180. doi: 10.3389/fimmu.2013.00180. eCollection 2013.
7
Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis.
Cytokine Growth Factor Rev. 2019 Feb;45:24-34. doi: 10.1016/j.cytogfr.2018.12.004. Epub 2018 Dec 19.
8
The interleukin-1 receptor family.
Semin Immunol. 2013 Dec 15;25(6):394-407. doi: 10.1016/j.smim.2013.10.023. Epub 2013 Nov 15.
9
The IL-1 family of cytokines and receptors in rheumatic diseases.
Nat Rev Rheumatol. 2019 Oct;15(10):612-632. doi: 10.1038/s41584-019-0277-8. Epub 2019 Sep 12.
10
Tuning of innate immunity and polarized responses by decoy receptors.
Int Arch Allergy Immunol. 2003 Oct;132(2):109-15. doi: 10.1159/000073711.

引用本文的文献

1
Emerging therapies for the treatment of systemic sclerosis.
Nat Rev Rheumatol. 2025 Sep 8. doi: 10.1038/s41584-025-01294-x.
2
Interleukin-6 in Cardiogenic Shock.
Curr Cardiol Rep. 2025 Aug 30;27(1):129. doi: 10.1007/s11886-025-02273-0.
4
Programmable protein ligation on cell surfaces.
Nature. 2025 Jul 30. doi: 10.1038/s41586-025-09287-2.
6
Modulation of adult hippocampal neurogenesis by interleukin 1 signaling.
Neurobiol Sleep Circadian Rhythms. 2025 Apr 25;18(Suppl):100123. doi: 10.1016/j.nbscr.2025.100123. eCollection 2025 May.
8
Dual targeting of tumoral cells and immune microenvironment by blocking the IL-33/IL1RL1 pathway.
Nat Commun. 2025 Jul 14;16(1):6369. doi: 10.1038/s41467-025-61567-7.
9
fruit extract antiulcerogenic effect: comparative study with lansoprazole and ranitidine in rats.
Front Med (Lausanne). 2025 Jun 25;12:1544422. doi: 10.3389/fmed.2025.1544422. eCollection 2025.

本文引用的文献

1
Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity.
Immunity. 2013 Nov 14;39(5):976-85. doi: 10.1016/j.immuni.2013.10.006. Epub 2013 Oct 24.
2
Macrophage plasticity and polarization in liver homeostasis and pathology.
Hepatology. 2014 May;59(5):2034-42. doi: 10.1002/hep.26754. Epub 2014 Apr 1.
3
Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies.
J Clin Invest. 2013 Nov;123(11):4695-705. doi: 10.1172/JCI71543.
5
Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.
J Clin Invest. 2013 Oct;123(10):4208-18. doi: 10.1172/JCI67119. Epub 2013 Sep 3.
6
Macrophage-derived IL-33 is a critical factor for placental growth.
J Immunol. 2013 Oct 1;191(7):3734-43. doi: 10.4049/jimmunol.1300490. Epub 2013 Aug 30.
7
Invariant natural killer T cells recognize a fungal glycosphingolipid that can induce airway hyperreactivity.
Nat Med. 2013 Oct;19(10):1297-304. doi: 10.1038/nm.3321. Epub 2013 Sep 1.
9
Structural insights into the interaction of IL-33 with its receptors.
Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):14918-23. doi: 10.1073/pnas.1308651110. Epub 2013 Aug 26.
10
Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis.
Immunity. 2013 Aug 22;39(2):357-71. doi: 10.1016/j.immuni.2013.07.018. Epub 2013 Aug 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验